VERU 241220 1.00C (VERU241220C1000) Stock Options, News & Quotes

0.01
0.000.00%

15min DelayClose Dec 20 16:00 ET

0.02High0.01Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Jaguar8

Nov 5 07:32

NEWS

$Veru Inc (VERU.US)$
Veru Announces Meta-analysis of Body Composition Data from Older Patients with Obesity which Supports Potential for Enobosarm to Optimize Weight Loss at ObesityWeek
Veru Inc. presented a meta-analysis of enobosarm's effects on body composition in older obese patients at ObesityWeek 2024. The analysis, based on four previous clinical trials, showed that enobosarm 3mg treatment led to better outcomes compared to placebo. By Day 147, enobosarm-treated subjects showed greater...

Rollercoaster05

Oct 24 14:03

Goooood newsss

$Veru Inc (VERU.US)$
Veru Inc | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.6%)

Jaguar8

Oct 16 07:31

NEWS

$Veru Inc (VERU.US)$
Veru to Deliver Keynote Presentation on the Scientific Support for Enobosarm in Combination with GLP-1 Receptor Agonist to Preserve Muscle for Higher Quality Weight Loss at the 4th Edition of the World Obesity and Weight Management Congress
Veru Inc. (NASDAQ: VERU) announced its participation in the World Obesity and Weight Management Congress, scheduled for October 24-26, 2024, in Baltimore, Maryland. The company will deliver a keynote presentation on October 25, 2024, f...

Trytosaveabit

Aug 8 05:34

Make a note! Only ifn you want? Didn’t mean to order you to do something you may not want to? Hehehe

$Veru Inc (VERU.US)$ Veru Inc: Topline Data for Primary Endpoint of Lean Body Mass Expected January 2025

Trytosaveabit

Jun 24 07:40

Update

$Veru Inc (VERU.US)$ Veru Presents Phase 2 and 3 Enobosarm Data At ADA Scientific Sessions: Well-Tolerated With Comparable Adverse Event Profile To Placebo; Effective In Reducing Fat And Preserving Lean Mass In Older Adults And Cancer Patients